|
FAM199X expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1691996783585E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75169999616642E-08 |
| Normal-vs-Stage2 |
6.977700E-03 |
| Normal-vs-Stage3 |
1.06660003051928E-09 |
| Normal-vs-Stage4 |
3.43109984868306E-10 |
| Stage1-vs-Stage2 |
9.564100E-02 |
| Stage1-vs-Stage3 |
1.719420E-01 |
| Stage1-vs-Stage4 |
1.115780E-02 |
| Stage2-vs-Stage3 |
1.520130E-02 |
| Stage2-vs-Stage4 |
3.404700E-03 |
| Stage3-vs-Stage4 |
2.759000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.8030005507278E-10 |
| Normal-vs-AfricanAmerican |
3.136800E-03 |
| Normal-vs-Asian |
2.53819999462834E-08 |
| Caucasian-vs-AfricanAmerican |
3.543200E-01 |
| Caucasian-vs-Asian |
2.783000E-01 |
| AfricanAmerican-vs-Asian |
1.161390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.26110000009794E-09 |
| Normal-vs-Female |
5.23249998884978E-09 |
| Male-vs-Female |
1.498420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02480000041538E-07 |
| Normal-vs-Age(41-60Yrs) |
4.67119998237564E-09 |
| Normal-vs-Age(61-80Yrs) |
2.47130000019524E-07 |
| Normal-vs-Age(81-100Yrs) |
1.618080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.521200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.024200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.945600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.011600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.157600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.904000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.183600E-02 |
| Classical-VS-Follicular |
1.027810E-01 |
| Classical-VS-Other |
2.822600E-01 |
| Classical-VS-Normal |
1.98109995075413E-09 |
| Tall-VS-Follicular |
6.842100E-03 |
| Tall-VS-Other |
6.579000E-01 |
| Tall-VS-Normal |
1.13600000517522E-08 |
| Follicular-VS-Other |
1.551410E-01 |
| Follicular-VS-Normal |
6.572200E-04 |
| Other-VS-Normal |
1.399030E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17780000033585E-07 |
| Normal-vs-N1 |
6.67579991286971E-10 |
| N0-vs-N1 |
2.493800E-02 |
|
|
